Lonza Signs Manufacturing Deal with Femta Pharmaceuticals
05:19 AM | December 16, 2009 | Deepti Ramesh
Lonza says it has signed a manufacturing services agreement with Femta Pharmaceuticals (San Diego, CA), to facilitate the development and manufacturing of FM101, a high affinity monoclonal antibody in...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.